 
 CONSENT  TO  PART IC IPATE  IN  A  CL IN ICAL  RESEARCH  STUDY 
   MED ICAL  RECORD                 •   Adu l t  Pa t ien t  o r      •   Pa ren t ,  fo r  M ino r  Pa t ie n t 
 
 INST ITUTE :  Na t iona l  Can ce r  In s t i tu te   STUDY  NUMBER : 07-C - [ADDRESS_1101998] IGATOR :   K ie ron  Dun leav y ,  M .D . 
  STUDY  T IT LE : A   Pha se   I / I I   S tud y   o f   F lavop i r ido l   in   Re lap sed   o r   Re f ra c to r y   Man t le   Ce l l   l ymphoma   (MC L )   and  
D i f fu se  La rge  B- ce l l  L ymphoma  (D LB C L ) 
  Con t inu ing  Rev iew  App ro ved  b y  the  IRB  on  6 /13 /11 Amendmen t  App ro ved  b y  IRB  on  06 /02 /11 ( I )          Da te  Po s ted  to  Web :   06 /10 /[ADDRESS_1101999]  
 
PAT IENT  IDENT IF ICAT ION CONSENT  TO  PART IC IPATE  IN  A  CL IN ICAL 
 RESEARCH  STUDY 
 
•    Adu l t  Pa t ien t  o r     •    Pa ren t ,  fo r  M ino r  Pa t ien t  
 N IH- 2514- 1  (07- 09 ) 
 P .A . :  09- 25- 0099 
 F i le  in  Se c t ion  4 :   P ro to co l  Con sen t  (1 ) 
 
 INTRODUCT ION  
 
We  in v i te  you  to  take  pa r t  in  a  re sea r ch  s tud y  a t  the  Na t iona l  In s t i tu te s  o f  Hea l th  (N IH ) .  F i r s t ,  we  wan t  you  to  know  tha t :  Tak ing  pa r t  in  N IH  re sea r ch  i s  en t i re l y  vo lun ta r y . 
  You  may  choo se  no t  to  take  pa r t ,  o r  you  may  w i thd raw  f rom  the  stud y  a t  an y  t ime .   In  e i the r  ca se ,  you  w i l l  no t  
lo se  an y  bene f i t s  to  wh i ch  you  a re  o the rw i se  en t i t led .   Howeve r ,  to  re ce i ve  ca re  a t  the  N IH ,  you  mu s t  be  tak ing  pa r t  in  a  s tud y  o r  be  unde r  eva lua t ion  fo r  s tud y  pa r t i c ipa t ion . 
  You  may  re ce i ve  no  bene f i t  f rom  tak ing  pa r t .   The  re sea r ch  may  g i ve  u s  know ledge  tha t  may  he lp  peop le  in  the  
fu tu re .  
 Se cond ,  some  peop le  have  pe r sona l ,  re l ig iou s  o r  e th i ca l  be l ie f s  tha t  may  l im i t  the  k ind s  o f  med i ca l  o r  re sea r ch  t rea tmen t s  they  wou ld  wan t  to  re ce i ve  ( su ch  a s  b lood  t ra n s fu s ion s ) .   I f  you  have  su ch  be l ie f s ,  p lea se  d i s cu s s  them  w i th  you r  N IH  do c to r s  o r  re sea r ch  team  be fo re  you  ag ree  to  the  s tud y .  Now  we  w i l l  de s c r ibe  th i s  re sea r ch  s tud y .   Be fo re  you  de c ide  to  take  pa r t ,  p lea se  take  a s  mu ch  t ime  a s  you  need  to  a s k  an y  ques t ion s  and  d i s cu s s  th i s  s tud y  w i th  an yone  a t  N IH ,  o r  w i th  fam i l y ,  f r iend s  o r  you r  pe r sona l  ph y s i c ian  o r  o the r  hea l th  p ro fe s s iona l .   
DESCR IPT ION  OF  RESEARCH  STUDY 
 
You  have  been  in v i ted  to  pa r t i c ipa te  in  th i s  s tud y  be cau se  you  have  e i the r  re lap sed  man t le  ce l l  l ymphoma  (MC L )  o r  d i f fu se  la rge  B - ce l l  l ymphoma  (D LBC L ) .   Th i s  i s  a  c l in i ca l  re sea r ch  s tud y  u s ing  a  d rug  ca l led  f lavop i r ido l .  F lavop i r ido l  i s  an  
in ve s t iga t iona l  d rug  tha t  ha s  been  shown  in  the  labo ra to r y  to  wo r k  in  a  d i f fe ren t  way  to  s tanda rd  chemo the r ap y .  I t s  e f fe c t i vene s s  may  depend  on  the  amoun t  o f  d rug  (do se )  and  s chedu le  ( t im ing  o f  d rug  do se ) .  Ea r l ie r  s tud ie s  o f  f lavop i r ido l  g i ven  on  a  d i f fe ren t  s chedu le  we re  no t  su c ce s s fu l .  The  s chedu le  tha t  you  w i l l  be  re ce i v ing  ha s  been  te s ted  on  pa t ien t s  w i th  a d i f fe ren t  type  o f  d i sea se  ca l led  ch ron i c  l ympho c y t i c  leu kem ia  (C L L ) .  Some  o f  the  pa t ien t s  w i th  C L L  who  re ce i ved  f lavop i r ido l  deve loped  a  comp l i ca t ion  ca l led  tumo r  l y s i s  s ynd rome  (T LS )  wh i ch  i s  whe re  the re  i s  a  qu i c k  dea th  o f  tumo r  ce l l s  wh i ch  may  cau se  the  amoun t  o f  po ta s s ium  and  o the r  sub s tan ce s  in  the  b lood s t ream  to  r i se  to  dange rou s  leve l s .  The  do se  wa s  then  lowe red  and  ce r ta in  pa t ien t s  w i th  ve r y  h igh  wh i te  ce l l  coun t s  mo s t  a t  r i s k  fo r  deve lop ing  T LS  we re  no t  t rea ted  w i th  f lavop i r ido l  un t i l  the i r  wh i te  coun t  wa s  lowe red .  S in ce  the se  change s ,  the  do se  and  s chedu le  tha t  you  w i l l  be  
 
 
  CONT INUAT ION  SHEET  fo r  e i the r : 
  MED ICAL  RECORD N IH  2514- 1 ,  Consen t  to  Pa r t ic ipa te  in  A  C l in ica l  Resea rch  S tudy 
 N IH  2514- 2 ,  M ino r  Pa t ien t ’s  Assen t  to Pa r t ic ipa te  In  A  C l in ica l  Resea rch  S tudy 
 
STUDY  NUMBER : 07-C - 0081 CONT INUAT ION :   page   2  o f   10   page s 
  
 
PAT IENT  IDENT IF ICAT ION CONT INUAT ION  SHEET  fo r  e i the r : 
 N IH- 2514- 1  (10- 84 ) 
 N IH- 2514- 2  (10- 84 ) 
 P .A . :  09- 25- [ADDRESS_1102000]  had .  Ou r  
goa l  i s  to  en ro l l  up  to  71  pa t ien t s  on  th i s  s tud y .   
 
The re  a re  seve ra l  abno rma l i t ie s  in  man t le  ce l l  and  d i f fu se  la rge  B- ce l l  l ymphoma  ce l l s  wh i ch  may  be  ta rge ted  b y  
f lavop i r ido l .  Fo r  e xamp le ,  a  type  o f  p ro te in  ca l led  c y c l in  D - 1  ha s  h igh  e xp re s s ion  in  man t le  ce l l  l ymphoma  ce l l s  and  
p robab l y  p reven t s  the  tumo r  ce l l s  f rom  d y ing .  C y c l in  D- 1  i s  a  ta rge t  o f  f lavop i r ido l  and  we  hope  tha t  b y  ta rge t ing  th i s  i t  w i l l  cau se  tumo r  ce l l s  to  d ie .  The re  a re  seve ra l  o the r  p ro te in s  in  bo th  man t le  ce l l  and  d i f fu se  la rge  B- ce l l  l ymphoma  ce l l s  wh i ch  may  be  ta rge ted  b y  f lavop i r ido l .  We  hope  tha t  b y  u s ing th i s  new  s chedu le ,  wh i ch  i s  ve r y  e f fe c t i ve  in  C L L ,  we  w i l l  see  good  re spon se s  wh i ch  w i l l  t ran s la te  in to  c l in i ca l  bene f i t  in  pa t ien t s  w i th  man t le  ce l l  and  d i f fu se  la rge  B - ce l l  l ymphoma .   
 
S tudy  Des ign : Be fo re  be ing  en ro l led  in  the  s tud y ,  you  w i l l  unde rgo  a se r ie s  o f  te s t s  to  de te rm ine  i f  you  a re  e l ig ib le  fo r  the  s tud y  and  to  de te rm ine  the  e x ten t  ( ca l led  s tage )  o f  you r  l ymphoma .   I f  you  a re  found  no t  to  be  e l ig ib le  fo r  the  s tud y ,  you  w i l l  be  re fe r red  ba c k  to  you r  home  ph y s i c ian .   I f  you  a re  e l ig ib le  and  de c ide  to  pa r t i c ipa te ,  we  w i l l  a s k  you  to  unde rgo  a  l ymph  node  b iop s y  be fo re  you  s ta r t  an y  t rea tmen t .  A s  pa r t  o f  you r  c l in i ca l  eva lua t ion  and  fo l low  up  we  w i l l  u se  CT  s can s  to  de te rm ine  the  e x ten t  o f  you r  d i sea se  and  re spon se  to  t rea tmen t .   
Adm in is t ra t ion  o f  flavop i r ido l :  F lavop i r ido l  i s  g i ven  in t ravenou s l y  ( IV—in to  a  ve in ) .  I t  may  be  g i ven  in  a  l i t t le  ca the te r  
in se r ted  on  the  day  o f  the  in fu s ion  o r  th rough  a  venou s  a c ce s s  dev i ce  (a l so  ca l led  cen t ra l  venou s  ca the te r ) .  I f  you  a l read y  
have  a  cen t ra l  venou s  ca the te r ,  a  new  one  w i l l  no t  be  p la ced .   I f  i t  i s  de te rm ined  tha t  you  need  a  cen t ra l  venou s  ca the te r ,  you   w i l l   be   g i ven   an   appo in tmen t   fo r   an   ou tpa t ien t   su rg i ca l   p ro cedu re   to   p la ce   the   ca the te r   in to   a   ve in   in   the   a rm   o r  che s t .   You   w i l l   re ce i ve   fu r the r   in fo rma t io n   abou t   the   p ro cedu re   and   the   ca the te r   f rom   the   c l in i c   tha t   pe r fo rm s   the se  p ro cedu re s . 
You  w i l l  be  adm i t ted  to  the  ho sp i ta l  to  re ce i ve  f lavop i r ido l  fo r  the  f i r s t  in fu s ion .   F lavop i r ido l  i s  g i ven  a s  a  4  and  a  ha l f hou r  
in fu s ion .   Some  o f  the  d rug  do se  i s  g i ven  o ve r  the  f i r s t  30  m inu te s ;  the  rema inde r  i s  in fu sed  o ve r  4  hou r s .   You  w i l l  re ce i ve  med i ca t ion s  fo r  nau sea  and  d ia r rhea .   Fo r  the  f i r s t  t rea tmen t ,  you  w i l l  be  g i ven  the  d rug  a l lopu r ino l  b y  mou th  and  f lu id  in to  you r  ve in s  to  p reven t  an  un l i ke l y ,  bu t  se r iou s ,  s ide  e f fe c t  ca l led  tumo r  l y s i s  s ynd rome  (wh i ch  o c cu r s  when  can ce r  ce l l s  d ie  too  rap id l y ) .  The  s tud y  do c to r  w i l l  de c ide  i f  on  sub sequen t  c y c le s  you  need  t rea tmen t  to  p reven t  tumo r  l y s i s  s ynd rome .   I f  you  do  no t  have  se r iou s  s ide  e f fe c t s ,  you  w i l l  go  h ome  the  fo l low ing  day . Th i s  t rea tmen t  w i l l  be  repea ted  week l y  fo r  4  week s  in  a  row ,  fo l lowed  b y  2  week s  w i th  no t rea tmen t .   Th i s  6  week  t ime  pe r iod  i s  ca l led  a  “ c y c le . ”  
A f te r  the  f i r s t  in fu s ion ,  the  rema in ing  t rea tmen t s  w i l l  be  in  the  ou tpa t ien t  c l in i c  a s  long  a s  you  do  no t  deve lop  se r iou s  s ide  
e f fe c t s .  You  may  go  home  2- [ADDRESS_1102001]  se r iou s  s ide  e f fe c t s  a s  an  ou tpa t ien t ,  you  
w i l l  be  ho sp i ta l i zed .  An y  fu r the r  f lavop i r ido l  wou ld  then  be  g i ven  to  you  in  the  ho sp i ta l .   
I f   y ou   deve lop   low   wh i te   b lood   coun t s   du r ing   f lavop i r ido l   t rea tmen t ,   we   w i l l   beg in   t rea tmen t   w i th   Neupogen  (G - CSF)  
wh i ch  can  cau se  you r  neu t roph i l  coun t  to  r i se .  On ce  we  s ta r t  Neupogen ,  we  w i l l  con t inue  i t  th roughou t  the  cou r se  o f  you r  
t rea tmen t  w i th  f lavop i r i do l . 
 Resea rch  tes ts :  We  wou ld  l i ke  to  pe r fo rm  re sea r ch  s tud ie s  on  you r  b lood ,  bone  ma r row ,  tumo r  t i s sue  o r  o the r  f lu id s  to  
loo k  a t  d i f fe ren t  gene s  and  p ro te in s  tha t  may  be  in vo l ved  in  the  deve lopmen t  o f  you r  l ymphoma  o r  the  rea c t ion  o f  the  immune  s y s tem .   We  w i l l  no t  e xam ine  mu ta t ion s  o f  no rma l  gene s  f rom  you r  t i s sue  w i thou t  ob ta in ing  add i t iona l  pe rm i s s ion  f rom  you .   We  p lan  to  do  a  t i s sue  b iop s y  be fo re  you  s ta r t  t rea tmen t  and  in  se le c ted  ca se s  a  se cond  b iop s y  a f te r  t rea tmen t  
 
 
  CONT INUAT ION  SHEET  fo r  e i the r : 
  MED ICAL  RECORD N IH  2514- 1 ,  Consen t  to  Pa r t ic ipa te  in  A  C l in ica l  Resea rch  S tudy 
 N IH  2514- 2 ,  M ino r  Pa t ien t ’s  Assen t  to Pa r t ic ipa te  In  A  C l in ica l  Resea rch  S tudy 
 
STUDY  NUMBER : 07-C - 0081 CONT INUAT ION :   page   3  o f   10   page s 
  
 
PAT IENT  IDENT IF ICAT ION CONT INUAT ION  SHEET  fo r  e i the r : 
 N IH- 2514- 1  (10- 84 ) 
 N IH- 2514- 2  (10- 84 ) 
 P .A . :  09- 25- 0099 
  
 ha s  begun .  The se  b iop s ie s  w i l l  g i ve  u s  impo r tan t  in fo rma t ion  abou t  you r  tumo r  and  the  e f fe c t s  o f  f lavop i r ido l  on  i t .  
B iop s ie s  requ i r ing  ma jo r  su rge r y  (e .g . ,  in  the  che s t  o r  the  abdomen )  w i l l  no t  be  pe r fo rmed  fo r  re sea r ch  pu rpo se s  a lone  
bu t  on l y  i f  ab so lu te l y  ne ce s sa r y  fo r  you r  med i ca l ca re .   Some  o f  the  re sea r ch  t i s sue  and  samp le s  ob ta ined  may  be  sen t  to  
cen te r s  ou t s ide  o f  the  Na t iona l  Can ce r  In s t i tu te  fo r  te s t s  to  be t te r  unde r s tand  how  f lavop i r ido l  wo r k s  in  can ce r  ce l l s .  
 
 L ymph  node  b iop s y :  
The  pu rpo se  o f  the  l ymph  node  b iop s y  i s  to  iden t i f y  b ioma r ke r s  tha t  may  p red i c t  how  a  pa t ien t  w i l l  re spond  to  f lavop i r ido l .   
P lea se  c lea r l y  che c k  the  app rop r ia te  bo x  be low :    I  am  vo lun tee r ing  to  take  pa r t  in  the  op t iona l  l ymph  node  b iop s y   
 
  I  am  NOT  vo lun tee r ing  to  take  pa r t  in  the  op t iona l  l ymph  node  b iop s y   
 Some  pa t ien t s  may  a l so  unde rgo  up  to  two  b iop s ie s  unde r  CT  gu idan ce  fo r  re sea r ch  pu rpo se s .  Th i s  rad ia t ion  i s  fo r  re sea r ch  pu rpo se s  on l y  and  i s  no t  ne ce s sa r y  fo r  you r  med i ca l  ca re .   
 
Ce r ta in  pa t ien t s  who  have  tumo r  ce l l s  in  the i r  b lood  s t ream  may  be  a s ked to  unde rgo  a  p ro cedu re  ca l led  l ymphaph e re s i s  
o r  aphe re s i s fo r  re sea r ch  pu rpo se s .  L ympha phere s i s  o r  aphe re s i s  i s  done  b y  c i r cu la t ing  you r  b lood  th rough  the  aphe re s i s  
ma ch ine .  To  do  th i s  you  mu s t  have  two  p la ce s  whe re  IV  need le s  a re  p la ced .  The re  a re  two  way s  to  do  th i s  p ro cedu re .  In  
the  f i r s t  me thod ,  a  need le  i s  p la ced  in to  ea ch  o f  you r  a rm  ve in s .  The  se cond  me thod  u se s  a  va s cu la r  a c ce s s  dev i ce .  Bo th  me thod s  p ro v ide  a  rou te  fo r  you r  b lood  to  be  c i r cu la ted  th rough  the  aphe re s i s  ma ch ine .  You r  blood  i s  remo ved  f rom  one  IV  s i te ,  and  then  f low s  th rough  the  tub ing  in to  the  ma ch ine .  The  ma ch ine  ha s  a  cen t r i fuge  tha t  sepa ra te s  the  pa r t  o f  the  b lood  tha t  i s  to  be  remo ved .  On l y  a  sma l l  po r t ion  o f  you r  b lood  i s  c i r cu la ted  th rough  the  ma ch ine  a t  an y  one  time .  The  b lood  then  re tu rn s  to  you  th rough  the  o the r  IV  s i te .  The  p ro cedu re  take s  [ADDRESS_1102002]  i f  you fee l  an y  o f  the se  s ide  e f fe c t s .  I t  i s  no rma l  to  fee l  
t i red  fo r  a  sho r t  t ime  a f te r  th i s  p ro cedu re .   Wha t  happens  a f te r  t rea tmen t  is  comp le ted :  Th i s  depend s  on  how  you  have  re sponded  to  the  the rap y .   I f  a l l  
ev iden ce  o f  d i sea se  ha s  d i sappea red ,  we  w i l l  s chedu le  pe r iod i c  v i s i t s  to  the  C l in i ca l  Cen te r  fo r  fo l low- up  e xam ina t ion  and  
te s t s .   I f  the  d i sea se  doe s  no t  d i sappea r  en t i re l y  o r  i f  i t  shou ld  re cu r  a f te r  hav ing  d i sappea red  fo r  a  pe r iod  o f  t ime ,  then  you  may  need  fu r the r  the rap y .   A t  tha t  t ime  you  w i l l  be  gi ven  the  oppo r tun i ty  o f  pa r t i c ipa t ing  in  add i t iona l  re sea r ch  p ro to co l s  tha t  may  be  app rop r ia te  fo r  you .   I f  no  su ch  p ro to co l s  a re  ava i lab le ,  you  w i l l  be  re tu rned  to  the  ca re  o f  you r  lo ca l  ph y s i c ian .   We  w i l l  con t inue  to  con ta c t  you  and /o r  you r  lo ca l  ph y s i c ian  to  see  how  you  a re  do ing  even  a f te r  you  have  comp le ted  t rea tmen t  on  th i s  p ro to co l .  I t  i s  impo r tan t  to  s t re s s  tha t  pa r t i c ipa t ion  in  th i s  p ro to co l  doe s  no t  con s t i tu te  a  p rom i se  o f  long- te rm  med i ca l  ca re  he re  a t  the  C l in i ca l  Cen te r .   I t  i s  con ce i vab le  tha t  pa r t i c ipa t ion  in  th i s  s tud y  may  make  
you  ine l ig ib le  to  pa r t i c ipa te  in  ce r ta in  o the r  re sea r ch  p ro to co l s  be cau se  the  requ i remen t s  fo r  en t r y  on to  the se  p ro to co l s  may  no t  a l low  pa t ien t s  who  have  a l read y  been  t rea ted  w i th  ce r ta in  d rug s  o r  who  have  had  ce r ta in s ide  e f fe c t s  f rom  p rev iou s  t rea tmen t .   You  may  de c ide  now  no t  to  re ce i ve  t rea tmen t  on  th i s  p ro to co l ,  o r  you  may  choo se  a t  an y  po in t  in  t ime  to  s top  the  t rea tmen t  and  w i thd raw  f rom  the  p ro to co l ;  in  e i the r  ca se  you  w i l l  be  re tu rned  to  the  ca re  o f  you r  re fe r r ing  ph y s i c ian .    
 
 
  CONT INUAT ION  SHEET  fo r  e i the r : 
  MED ICAL  RECORD N IH  2514- 1 ,  Consen t  to  Pa r t ic ipa te  in  A  C l in ica l  Resea rch  S tudy 
 N IH  2514- 2 ,  M ino r  Pa t ien t ’s  Assen t  to Pa r t ic ipa te  In  A  C l in ica l  Resea rch  S tudy 
 
STUDY  NUMBER : 07-C - 0081 CONT INUAT ION :   page   4  o f   10   page s 
  
 
PAT IENT  IDENT IF ICAT ION CONT INUAT ION  SHEET  fo r  e i the r : 
 N IH- 2514- 1  (10- 84 ) 
 N IH- 2514- 2  (10- 84 ) 
 P .A . :  09- 25- 0099 
  
 ALTERNAT IVE  APPROACHES  OR  TREATMENTS   
 
A l te rna t i ve  p ro cedu re s  tha t  cou ld  be  used  to  t rea t  you r  d i sea se  in c lude :   1 .   Comb ina t ion  d rug  reg imen s .  The re  a re  seve ra l  d rug s  wh i ch  a re  ve r y  a c t i ve  in  d i f fu se  la rge  B- ce l l  l ymphoma  and  
man t le  ce l l l ymphoma .   
2 .   T rea tmen t  w i th  s ing le  d rug s .   
3 .   Rad ia t ion  (X- ray )  t rea tmen t s .   Th i s  can  s top  tumo r  g row th  in  pa r t i cu la r  lo ca t ion s ,  su ch  a s  bone ,  abdomen ,  and  
o the r  s i te s  bu t  i s  no t  su c ce s s fu l  in  con t ro l l ing  the  d i sea se  o ve ra l l  un le s s  the  d i sea se  i s  ve r y  lo ca l i zed  a t  the  s ta r t  o f  
the rap y .   
[ADDRESS_1102003] s  p re sent  in  
mu l t ip le  lo ca t ion s .   A l so ,  su rge r y  canno t  be  u sed  aga in s t  tumo r  in  some  o f  the  o rgan s  mo s t  common l y  in vo l ved  b y  l ymphoma ,  su ch  a s  the  l i ve r  o r  the  lung s .  
5 .    Bone  ma r row  t ran sp lan ta t ion  may  be  an  a l te rna t i ve  type  o f  t rea tmen t .  Th i s  can  be  cu rab le  in  some  pa t ien t s  w i th  
re lap sed  o r  re f ra c to r y  man t le  ce l l  l ymphoma  o r  d i f fu se  la rge  B - ce l l  l ymphoma .   
6 . Wa t ch ing  and  wa i t ing  may  be  an  op t ion  fo r  se le c t  pa t ien t s  w i thou t  s ymp tom s . 
7 .     Ge t t ing  no  t rea tmen t ;  ge t t ing  com fo r t  ca re ,  a l so  ca l led  pa l l ia t i ve  ca re .  Th i s  type  o f  ca re  he lp s  redu ce  pa in ,  
t i redne s s ,  appe t i te  p rob lem s ,  and  o the r  p rob lem s  cau sed  b y  can ce r .  I t  doe s  no t  t rea t  the  can ce r  d i re c t l y ,  bu t  in s tead  t r ie s  to  imp ro ve  how  you  fee l .  Com fo r t  ca re  t r ie s  to  keep  you  a s  a c t i ve  and  com fo r tab le  a s  po s s ib le .  
RISKS  OR  D ISCOMFORTS  OF  PART IC IPAT ION  
 
In  o rde r  to  de te rm ine  whe the r  th i s  s tud y  i s  su i tab le  fo r  you ,  a  numbe r  o f  te s t s  w i l l  have  to  be  done .    Some  o r  a l l  o f  the se  te s t s  w i l l  be  repea ted  du r ing  and  a f te r  the  f lavop i r ido l  a t  d i f fe ren t  t ime s .   Depend ing  on  th e  te s t s  you  had  be fo re  com ing  he re ,  the se  may  in c lude  b lood  and  u r ine  te s t s ,  s tud ie s  o f  lung  fun c t ion ,  CAT  o r  MR I  s can s ,  rad io i so tope  s can s  ( fo r  e xamp le  a  PET  s can ) ,  co lono s cop ie s ,  and  b iop s ie s  o f  tumo r  t i s sue ,  bone  ma r row ,  l i ve r ,  o r  o the r  s i te s .   B iop s ie s w i l l ,  when  po s s ib le ,  be  done  unde r  lo ca l  ane s the s ia .   The  r i s k s  a s so c ia ted  w i th  bone  ma r row  b iop s ie s  in c lude  pa in ,  b leed ing ,  and  lo ca l  in fe c t ion .   R i s k s  o f  b iop s ie s  in c lude  pa in ,  b leed ing ,  in fe c t ion ,  and  the  r i s k s  to  the  pa r t i cu la r  a rea  unde rgo ing  su rge r y .   Gene ra l  ane s the s ia  i t se l f  i s  gene ra l l y  ve r y  sa fe  bu t  ha s  a  ve r y  sma l l  r i s k  o f  ma jo r  comp l i ca t ion s  su ch  a s  hea r t  a t ta c k  o r  s t ro ke .   The  su rg i ca l  and  ane s the t i c  r i s k s  w i l l  be  e xp la ined  to  you  in  mo re  de ta i l  a t  the  t ime  o f  su rge r y ,  i f  th i s  i s  needed .   R i s ks  o f  co lono s cop y  w i th  b iop s ie s  in c lude  d i s com fo r t  and  b leed ing  f rom  the  re c tum ;  ra re l y  the  co lon  may  be  pun c tu red  and  i f  th i s  o c cu r s ,  i t  i s  se r iou s  and  may  requ i re  su rge r y .    A  sepa ra te  con sen t  de s c r ib ing  a l l  o f  the  comp l i ca t ion s  and  s ide  e f fe c t s  o f  co lonos cop y  w i th  b iop s ie s  w i l l  be  ob ta ined  f rom  you .    In  o rde r  to  re ce i ve  th i s  the rap y  i t  i s  po s s ib le  tha t  you  w i l l  need  to  have  an  in t ravenou s  ca the te r  p la ced .   Th i s  ca the te r  i s  u sua l l y  p la ced  in  the  a rm ,  che s t  o r  ne c k  a rea  in to  a  ma jo r  ve in  in s ide  you r  che s t .   We  u sua l l y  remo ve  the  ca the te r  a f te r  ea ch  c y c le  bu t  on  o c ca s ion  i t  can  be  le f t  in  fo r  seve ra l  c y c le s .   The  ca the te r  may  be  ne ce s sa r y  fo r  in fu s ion  o f  f lavop i r ido l  and  fo r  the  d raw ing  o f  b lood .   I t  i s  u sua l l y  in se r ted  unde r  lo ca l  ane s the s ia .   The  r i s k s  a s so c ia ted  w i th  the  p ro cedu re  in c lude  pa in ,  b leed ing ,  in fe c t ion ,  and  pun c tu re  o f  the  unde r l y ing  lung .   Lung  pun c tu re  can  re su l t  in  lung  co l lap se ,  wh i ch  m igh t  requ i re  tha t  a  che s t  tube  be  p la ced  in to  the  che s t  cav i ty  (u sua l l y  fo r  a  day  o r  two )  to  he lp  the  lung re - in f la te .   The  long - te rm  r i s k s  o f  the  ca the te r  in c lude  in fe c t ion  and  c lo t t ing  o f  the  ve in  in  wh i ch  the  ca the te r  s i t s .   I f  the se  o c cu r ,  i t  may  be  ne ce s sa r y  to  remo ve  the  ca the te r .   The se  r i s k s  w i l l  be  e xp la ined  to  you  in  mo re  de ta i l  a t  the  t ime  o f  the  inse r t ion .   
 
 
  CONT INUAT ION  SHEET  fo r  e i the r : 
  MED ICAL  RECORD N IH  2514- 1 ,  Consen t  to  Pa r t ic ipa te  in  A  C l in ica l  Resea rch  S tudy 
 N IH  2514- 2 ,  M ino r  Pa t ien t ’s  Assen t  to Pa r t ic ipa te  In  A  C l in ica l  Resea rch  S tudy 
 
STUDY  NUMBER : 07-C - 0081 CONT INUAT ION :   page   5  o f   10   page s 
  
 
PAT IENT  IDENT IF ICAT ION CONT INUAT ION  SHEET  fo r  e i the r : 
 N IH- 2514- 1  (10- 84 ) 
 N IH- 2514- 2  (10- 84 ) 
 P .A . :  09- 25- 0099 
  
 Poss ib le  s ide  e f fec ts  o f  F lavop i r ido l : 
 
L ike ly : 
•  La c k  o f  enough  red  b lood  ce l l s  (anem ia ) 
•  D ia r rhea 
•  Nau sea  o r  the  u rge  to  vom i t 
•  Vom i t ing  
•  Fa t igue  o r  t i redne s s 
•  De c rea sed  numbe r  o f  a  type  o f  wh i te  b lood  ce l l  (neu t roph i l /g ranu lo c y te ) 
•  De c rea sed  numbe r  of  a  type  o f  b lood  ce l l  tha t  he lp  to  c lo t  b lood  (p la te le t )  
•  De c rea se  in  the  to ta l  numbe r  o f  wh i te  b lood  ce l l s  ( leu ko c y te s ) 
 
Less  L ike ly : 
•  Feve r  a s so c ia ted  w i th  dange rou s l y  low  leve l s  o f  a  type  o f  wh i te  b lood  ce l l  (neu t roph i l s ) •  Be l l y  pa in •  Ch i l l s  •  Feve r •  Pa in  
•  Po ten t ia l l y  l i fe- th rea ten ing  cond i t ion  du r ing  a  d rug  in fu s ion  wh i ch  may  cau se  low  b lood  p re s su re ,  ra sh ,  feve r ,  
ch i l l s ,  d i f f i cu l ty  b rea th ing ,  rap id  hea r tbea t ,  nau sea ,  and  k idney  damage  
•  In fe c t ion  
•  In c rea sed  b lood  leve l  o f  a  l i ve r  en z yme  (A LT /SGPT )  
•  In c rea sed  b loo d  leve l  o f  a  l i ve r  en z yme  (AST /SGOT ) 
•  In c rea sed  b lood  leve l  o f  a  l i ve r  p igmen t  (b i l i rub in )  o f ten  a  s ign  o f  l i ve r  p rob lem s  
•  De c rea sed  numbe r  o f  a  type  o f  wh i te  b lood  ce l l  ( l ympho c y te ) 
•  Lo s s  o f  appe t i te 
•  H igh  b lood  suga r  leve l 
•  De c rea sed  leve l s  o f  a  b lood  p ro te in ca l led  a lbum in  
•  De c rea sed  b lood  leve l  o f   pho spha te 
•  H igh  o r  low  b lood  ca l c ium 
•  G roup  o f  s ign s  and  s ymp tom s  due  to  rap id  b reakdown  o f  tumo r  tha t  can  o c cu r  a f te r  t rea tmen t  o f  can ce r  ha s  s ta r ted  tha t  cau se s  in c rea sed  leve l s  o f  b lood  po ta s s ium ,  u r i c  a c id ,  and  pho spha te ,  de c rea sed  leve l s  o f  b lood  ca l c ium ,  and  k idney  fa i lu re  
•  In c rea sed  c rea t in ine  (b lood  te s t  tha t  ind i ca te s  k idney  fun c t ion )  
•  Mu s c le  pa in 
•  Pa in  in  the  a rea  o f  the  tumo r 
•  Ta s te  change s 
•  B leed ing  f rom  the  b ra in 
•  Sho r tne s s  o f  b rea th 
•  Ha i r  lo s s 
•  Low  b lood  p re s su re  
•  Fa in t ing 
•  Fo rma t ion  o f  a  b lood  c lo t  tha t  b reak s  loo se  and  i s  ca r r ied  b y  the  b lood  s t ream  to  p lug  ano the r  b lood  ve s se l 
 
 
  CONT INUAT ION  SHEET  fo r  e i the r : 
  MED ICAL  RECORD N IH  2514- 1 ,  Consen t  to  Pa r t ic ipa te  in  A  C l in ica l  Resea rch  S tudy 
 N IH  2514- 2 ,  M ino r  Pa t ien t ’s  Assen t  to Pa r t ic ipa te  In  A  C l in ica l  Resea rch  S tudy 
 
STUDY  NUMBER : 07-C - 0081 CONT INUAT ION :   page   6  o f   10   page s 
  
 
PAT IENT  IDENT IF ICAT ION CONT INUAT ION  SHEET  fo r  e i the r : 
 N IH- 2514- 1  (10- 84 ) 
 N IH- 2514- 2  (10- 84 ) 
 P .A . :  09- 25- 0099 
  
  
I f  you  rece ive  Neupogen ,  the  poss ib le  s ide  e f fec ts  inc lude :   
•  Bon y  pa in   
•  S k in  ra sh 
•  S k in  redden ing  a round  the  in je c t ion  s i te 
•  Mu s c le  c ramp s 
•  De c rea sed  p la te le t s  (no t  c l in i ca l l y  s ign i f i can t ) •  Pa in  o r  numbne s s  and  t ing l ing  a round  the  ch in 
•  Wo r sen ing  o f  ce r ta in  p re- e x i s t ing  in f lamma to r y  cond i t ion s  ( su ch  a s  p so r ia s i s  e c zema ,  o r  va s cu l i t i s ) 
•  Feve r ,  bod y  a che s 
•  A l te ra t ion s  in  ce r ta in  labo ra to r y  te s t s 
•  W ith  p ro longed  adm in i s t ra t ion  Neupogen  ha s  been  a s so c ia ted  w i th  ha i r  th inn ing  and  en la rgemen t  o f  the  sp leen .   
 
In  add i t ion  to  the  abo ve  l i s ted  s ide  e f fe c t s ,  un fo re seeab le  o r  une xpe c ted  r i s k s ,  in c lud ing  dea th  may  be  in vo l ved  w i th  th i s  d rug .  You r  ph y s i c ian s  w i l l  wa t ch  you  c lo se l y  fo r  s ide  e f fe c t s  and  w i l l  s top  t rea tmen t  i f  an y  s ide  e f fe c t s  be come  a  se r iou s  th rea t  to  you r  l i fe  o r  we l l - be ing .   You r  ph y s i c ian s  w i l l  a l so  s top  the  t rea tmen t s  i f  i t  be come s  c lea r  tha t  the  t rea tmen t  i s  no t  su c ce s s fu l l y  con t ro l l ing  you r  d i sea se .  
You  shou ld  no t  be come  p regnan t  o r  fa the r  a  bab y  wh i le  on  th i s  s tud y  be cau se  the  d rug  in  th i s  s tud y  can  a f fe c t  an  unbo rn  
bab y .  Women  shou ld  no t  b rea s t feed  a  bab y  wh i le  on  th i s  s tud y .  I t  i s  impo r tan t  you  unde r s tand  tha t  you  need  to  u se  b i r th  con t ro l  wh i le  on  th i s  s tud y .  Che c k  w i th  you r  s tud y  do c to r  abou t  wha t  k ind  o f  b i r th  con t ro l  me thod s  to  u se  and  how  long  to  u se  them .  Some  me thod s  m igh t  no t  be  app ro ved  fo r  u se  in  th i s  s tud y .  F lavop i r ido l  may  be  to x i c  to  the  ce l l s  in  the  o va r y  and  te s t i c le  and  may  p rodu ce  s te r i l i ty .   Re co ve r y  o f  no rma l  fe r t i l i ty  i s  no t  we l l  s tud ied .   Fo r  th i s  rea son ,  men  who  a re  abou t  to  re ce i ve  th i s  t rea tmen t  shou ld ,  i f  they  w i sh  to  have  ch i ld ren  in  the  fu tu re ,  con s ide r  spe rm  ban k ing  be fo re  s ta r t  o f  the  t rea tmen t .   Women  o f  ch i ldbea r ing  age  w i l l  have  a  p regnan c y  te s t ,  wh i ch  mu s t  be  nega t i ve  a t  the  t ime  o f  s tud y  en t r y .   Th i s  te s t  requ i re s  tha t  a  u r ine  samp le  be  ob ta ined  w i th in  one  week  p r io r  to  the  s tud y .   The  re su l t s  o f  the  p regnan c y  te s t  w i l l  be  made  ava i lab le  to  you  p r io r  to  the in i t ia t ion  o f  the  s tud y .   
Ra re l y ,  pa t ien t s  may  deve lop  a  dange rou s  s ide  e f fe c t  f rom  b lood  t ran s fu s ion s  ca l led  g ra f t  ve r su s  ho s t  d i sea se  (GVH ) .   Th i s  
d i sea se  i s  cau sed  b y  wh i te  ce l l s  f rom  the  b lood  t ran s fu s ion  tha t  can  a t ta c k  you r  no rma l  t i s sue s  and  cau se  dea th .   GVH  i s  p reven tab le  b y  rad ia t ing  the  b lood  be fo re  you  re ce i ve  i t .   I t  i s  impo r tan t  to  empha s i ze  tha t  you  w i l l  no t  re ce i ve  an y  rad ia t ion  f rom  the  b lood  and  the  rad ia t ion  p ro cedu re  done  on  the  dona ted  b lood  w i l l  no t  ha rm  you .   I f  you  requ i re  a  b lood  t ran s fu s ion  a t  the  N IH  du r ing  th i s  s tud y ,  you  w i l l  re ce i ve  b lood  tha t  ha s  been  rad ia ted .   Howeve r ,  i f  you r  lo ca l  ph y s i c ian  g i ve s  you  a  b lood  t ran s fu s ion ,  i t  i s  impo r tan t  tha t  you  make  su re  the  b lood  ha s  been  rad ia ted . 
Th i s  re sea r ch  s tud y  in vo l ve s  e xpo su re  to  rad ia t ion  f rom  one  to  two  CT  s can s .  P lea se  no te  tha t  th i s  rad ia t ion  e xpo su re  i s  
no t  ne ce s sa r y  fo r  you r  med i ca l  ca re  and  i s  fo r  re sea r ch  pu rpo se s  on l y .  I f  you  a re  an  adu l t ,  the  to ta l  amoun t  o f  rad ia t ion  you  w i l l  re ce i ve  in  th i s  s tud y  i s  f rom  [ADDRESS_1102004]  o f  de s c r ib ing  rad ia t ion  do se ,  f rom  pa r t i c ipa t ing  in  th i s  s tud y,  you  w i l l  re ce i ve ( f rom  two  CT  s can s )  
a  to ta l  o f  8 .0 rem  to  you r  k idney s  and  5 .2 rem  ea ch  to  you r  s toma ch ,  ga l lb ladde r  wa l l  and  lowe r  la rge  in te s t ine .   A l l  o the r  
o rgans   w i l l   re ce i ve   sma l le r   amoun t s   o f   rad ia t ion .     A l though   ea ch   o rgan   w i l l   re ce i ve   a   d i f fe ren t   do se ,   the   amoun t   o f  rad ia t ion   e xpo su re   you   w i l l   re ce i ve   f rom   the se   p ro cedu re s   i s   equa l   to   a   un i fo rm   who le - bod y   e xpo su re   o f  1 .2  rem .   Th i s  
ca l cu la ted  va lue  i s  known  a s  the  “e f fe c t i ve  do se ”  and  i s  u sed  to  re la te  the  do se  re ce i ved  b y  ea ch  o rgan  to  a  s ing le  va lue .   The   amoun t   o f   rad ia t ion   re ce i ved   in   th i s   s tud y   i s  w i th in  the   do se   gu ide l ine   e s tab l i shed   b y   the   N IH   Rad ia t ion   Sa fe ty  Comm i t tee  fo r  re sea r ch  sub je c t s .   The  gu ide line  i s  fo r  an  e f fe c t i ve  do se  no t  to  e x ceed  5  rem  re ce i ved  pe r  yea r  in  adu l t s .  
 
 
  CONT INUAT ION  SHEET  fo r  e i the r : 
  MED ICAL  RECORD N IH  2514- 1 ,  Consen t  to  Pa r t ic ipa te  in  A  C l in ica l  Resea rch  S tudy 
 N IH  2514- 2 ,  M ino r  Pa t ien t ’s  Assen t  to Pa r t ic ipa te  In  A  C l in ica l  Resea rch  S tudy 
 
STUDY  NUMBER : 07-C - 0081 CONT INUAT ION :   page   7  o f   10   page s 
  
 
PAT IENT  IDENT IF ICAT ION CONT INUAT ION  SHEET  fo r  e i the r : 
 N IH- 2514- 1  (10- 84 ) 
 N IH- 2514- 2  (10- 84 ) 
 P .A . :  09- 25- [ADDRESS_1102005]  been  ob se r ved ,  some  s c ien t i s t s  be l ieve  tha t  rad ia t ion  can  be  ha rm fu l  a t  an y  do se  -  even  low  do se s  su ch  a s  tho se  re ce i ved  du r ing  th i s  re sea r ch .   One  po s s ib le  e f fe c t  tha t  cou ld  o c cu r  a t  the se  do se s  i s  a  s l igh t  in c rea se  in  the  r i s k  o f  can ce r .  P lea se  be  awa re  tha t  the  na tu ra l  chan ce  o f  a  pe r son  ge t t ing  a  fa ta l  can ce r  du r ing  h i s /he r  l i fe t ime  i s  abou t  1  ou t  o f  4  (o r  25 pe r cen t ) .  The  in c rea se  in  the  chan ce  o f  ge t t ing  a  fa ta l  can ce r ,  a s  a  re su l t  o f  the  rad ia t ion  e xpo su re  re ce i ved  f rom  th i s  re sea r ch  s tud y ,  i s  e s t ima ted  a t  [ADDRESS_1102006]  taken  pa r t  in  o the r  re sea r ch  s tud ie s  o r  re ce i ved  an y  med i ca l  ca re  a t  the  N IH  o r  o the r  p la ce s /ho sp i ta l s  tha t  u sed  rad ia t ion .   Th i s  way  we  can  make  su re  tha t  you  w i l l  no t  re ce i ve  too  mu ch  rad ia t ion .   Con s ide r  x - ray s  taken  in  rad io log y  depa r tmen t s ,  ca rd ia c  ca the te r i za t ion ,  and  f luo ro s cop y  a s  we l l  a s  nu c lea r  med i c ine  s can s  in  wh i ch  rad ioa c t i ve  ma te r ia l s  we re  in je c ted  in to  you r  bod y .   I f  you  wou ld  l i ke  mo re  in fo rma t ion  abou t  rad ia t ion  and  e xamp le s  o f  e xpo su re  leve l s  f rom  o the r  sou r ce s ,  p lea se  a s k  the  in ve s t iga to r  fo r  a  cop y  o f  the  pamph le t  ca l led ,  An  In t rodu c t ion  to  Rad ia t ion  fo r  N IH  Re sea r ch  Sub je c t s .  I f   you   a re   p regnan t   you   may   no t   pa r t i c ipa te   in   th i s   re sea r ch   s tud y .     I t   i s   be s t   to   avo id   rad ia t ion   e xpo su re   to   unbo rn  ch i ld ren  s in ce  they  a re  mo re  sen s i t i ve  to  rad ia t ion  than  adu l t s .   
POTENT IAL  BENEF ITS  OF  PART IC IPAT ION 
We  hope  tha t  some  pa t ien t s  w i l l  have  tumo r  sh r in kage  w i th  f lavop i r ido l .  Howeve r ,  i t  i s  po s s ib le  tha t  you  may  no t  re spond  
to  an y  o f  th i s  t rea tmen t .  
RESEARCH  SUBJECT ’S  R IGHTS 
 
An y  comp l i ca t ion  a r i s ing  f rom  th i s  trea tmen t  w i l l  re ce i ve  fu l l  and  p romp t  med i ca l  a t ten t ion .   Howeve r ,  the  Na t iona l  Can ce r  In s t i tu te ,  Fede ra l  Go ve rnmen t ,  and  the  C l in i ca l  Cen te r  do  no t  p ro v ide  f inan c ia l  compen sa t ion  fo r  in ju r y  o r  long - te rm  
 
 
  CONT INUAT ION  SHEET  fo r  e i the r : 
  MED ICAL  RECORD N IH  2514- 1 ,  Consen t  to  Pa r t ic ipa te  in  A  C l in ica l  Resea rch  S tudy 
 N IH  2514- 2 ,  M ino r  Pa t ien t ’s  Assen t  to Pa r t ic ipa te  In  A  C l in ica l  Resea rch  S tudy 
 
STUDY  NUMBER : 07-C - 0081 CONT INUAT ION :   page   8  o f   10   page s 
  
 
PAT IENT  IDENT IF ICAT ION CONT INUAT ION  SHEET  fo r  e i the r : 
 N IH- 2514- 1  (10- 84 ) 
 N IH- 2514- 2  (10- 84 ) 
 P .A . :  09- 25- [ADDRESS_1102007]  no  r igh t s  to  an y  pa ten t s  o r  d i s co ve r ie s  a r i s ing  f rom  th i s  re sea r ch ,  
and  you  w i l l  re ce i ve  no  e conom i c  bene f i t . You r  med i ca l  ca re  and  the  co s t s  o f  the  labo ra tor y  and  rad iog raph i c  s tud ie s  done  
a t  the  C l in i ca l  Cen te r ,  N IH  w i l l  be  a t  no  e xpen se  to  you .   I f  the  b lood  te s t s  needed  to  mon i to r  the  e f fe c t s  o f  t rea tmen t  a re  
to  be  done  b y  you r  lo ca l  ph y s i c ian ,  you  can  be  re imbu r sed  fo r  the  co s t s  i f  you r  in su ran ce  doe s  no t  co ve r  th i s  e xpen se ;  
pe rm i s s ion  fo r  th i s  mu s t  be  ob ta ined  b y  you r  N IH  ph y s i c ian  in  ad van ce .   The  N IH  canno t ,  howeve r ,  re imbu r se  you  fo r  the  
co s t s  o f  o the r  type s  o f  med i ca l  ca re  de l i ve red  ou t s ide  the  N IH ,  even  i f  you  a re  seek ing  med i ca l  a t ten t ion  a s  a  re su l t  o f  
s ide  e f fe c t s  f rom  t rea tmen t  g i ven  he re ,  un le s s  pe rm i s s ion  i s  g ran ted  in  ad van ce  b y  the  p r in c ipa l  in ve s t iga to r  o f  th i s  s tud y .   
S im i la r l y ,  we  do  no t  o rd ina r i l y  re imbu r se  the  co s t s  o f  d iagno s t i c  rad io log y  te s t s  ( su ch  a s  CT  s can s ,  MR I ,  o r  che s t  X- ray s )  
done  ou t s ide  the  N IH ,  even  i f  they  a re  done  fo r  the  pu rpo se s  o f  th i s  s tud y .   
 
NEW  INFORMAT ION  
You  w i l l  be  in fo rmed  o f  an y  new  f ind ing s  re la ted  to  the  deve lopmen t  o r  sa fe ty  o f  f lavop i r ido l  tha t  may  a f fe c t  you r  
w i l l ingne s s  to  con t inue  to  take  pa r t  in  th i s  s tud y . 
 
EARLY  TERM INAT ION  You  w i l l  be  d i s con t inued  f rom  th i s  s tud y  fo r  an y  o f  the  fo l low ing  rea son s :  
•  You  may  be  w i thd rawn  f rom  the  s tud y  i f  you  do  no t  comp l y  w i th  the  s tud y  requ i remen t s . •  You r  do c to r s  do  no t  fee l  i t  i s  in  you r  med i ca l  be s t  in te re s t s  to  be  con t inued  on  th i s  s tud y . 
•  You  have  had  una c cep tab le  to x i c i ty  wh i ch  doe s  no t  pe rm i t  sa fe  con t inua t ion  on  the  s tud y •  You  requ i re  ano the r  t rea tmen t . 
 MAK ING  YOUR  CHO ICE  We  wou ld  l i ke  to  keep  some  o f  the  b lood / t i s sue  tha t  i s  le f t  o ve r  fo r  fu tu re  re sea r ch .   The se  spe c imen s  w i l l  be  iden t i f ied  b y  a  numbe r  and  no t  you r  name .   The  u se  o f  you r  spe c imen s  w i l l  be  fo r  re sea r ch  pu rpo se s  on l y  and  w i l l  no t  bene f i t  you .   I t  i s  a l so  po s s ib le  tha t  the  s to red  spe c imen s  may  neve r  be  u sed .   Re su l t s  o f  the  re sea r ch  done  on  you r  spe c imen s  w i l l  no t  be  ava i lab le  to  you  o r  you r  do c to r .   I t  m igh t  he lp  peop le  who  have  can ce r  and  o the r  d i sea se s  in  the  fu tu re .    I f  you  de c ide  now  tha t  you r  b lood / t i s sue  can  be  kep t  fo r  fu tu re  re sea r ch ,  you  can  change  you  m ind  a t  an y  t ime .   Ju s t  con ta c t  u s  and  le t  u s  know  tha t  you  do  no t  wan t  u s  to  u se  you r  b lood / t i s sue .   Then  an y  rema in ing  b lood / t i s sue  tha t  rema in s  w i l l  be  de s t ro yed .    P lea se  read  ea ch  sen ten ce  be low  and  th in k  abou t  you  cho i ce .   A f te r  read ing  ea ch  sen ten ce ,  c i r c le  and  in i t ia l  the  an swe r  tha t  i s  r igh t  fo r  you .   I f  you  have  an y  que s t ion s ,  p lea se  ta l k  to  you r  do c to r  o r  nu r se .   No  ma t te r  wha t  you  de c ide  to  do ,  i t  w i l l  no t  a f fe c t  you r  ca re .   1 . M y  b lood / t i s sue  may  be  kep t  fo r  u se  in  re sea r ch  to  lea rn  abou t ,  p reven t  o r  t rea t  can ce r .    
Ye s         No    In i t ia l s _____________ 
 
 
  CONT INUAT ION  SHEET  fo r  e i the r : 
  MED ICAL  RECORD N IH  2514- 1 ,  Consen t  to  Pa r t ic ipa te  in  A  C l in ica l  Resea rch  S tudy 
 N IH  2514- 2 ,  M ino r  Pa t ien t ’s  Assen t  to Pa r t ic ipa te  In  A  C l in ica l  Resea rch  S tudy 
 
STUDY  NUMBER : 07-C - 0081 CONT INUAT ION :   page   9  o f   10   page s 
  
 
PAT IENT  IDENT IF ICAT ION CONT INUAT ION  SHEET  fo r  e i the r : 
 N IH- 2514- 1  (10- 84 ) 
 N IH- 2514- 2  (10- 84 ) 
 P .A . :  09- 25- 0099 
  
  
2 . M y  b lood / t i s sue  may  be  kep t  fo r  u se  in  re sea r ch  to  lea rn  abou t ,  p reven t  o r  t rea t  o the r  hea l th  p rob lem s  ( fo r  e xamp le :  
d iabe te s ,  A l zhe ime r ’ s  d i sea se ,  o r  hea r t  d i sea se ) . 
 
Ye s         No    In i t ia l s _____________ 
 
3 . Someone  may  con ta c t  me  in  the  fu tu re  to  a s k  pe rm i s s ion  to  u se  my  spe c imen ( s )  in  new  re sea r ch  a t  the  N IH  no t  
in c luded  in  th i s  con sen t .   
 
Ye s         No    In i t ia l s _____________ 
 
 
  CONSENT  TO  PART IC IPATE  IN  A  CL IN ICAL  RESEARCH  STUDY 
   MED ICAL  RECORD •  Adu l t  Pa t ien t  o r     •  Pa ren t ,  fo r  M ino r  Pa t ien t 
 
STUDY  NUMBER : 07-C - 0081 CONT INUAT ION :   page   10  o f   10   page s 
 
PAT IENT  IDENT IF ICAT ION CONSENT  TO  PART IC IPATE  IN  A  CL IN ICAL 
 RESEARCH  STUDY  (Con t inua t ion  Shee t ) 
 •   Adu l t  Pa t ien t  o r    •   Pa ren t ,  fo r  M ino r  Pa t ien t  
 N IH- 2514- 1  (07- 09 ) 
 P .A . :  09- 25- 0099 
 F i le  in  Se c t ion  4 :   P ro to co l  Con sen t 
 
 OTHER  PERT INENT  INFORMAT ION 
[ADDRESS_1102008] .   Th i s  
in fo rma t ion  m igh t  a f fe c t  (e i the r  favo rab l y  o r  un favo rab l y )  the  w i l l ingne s s  o f  the  in su ran ce  compan y  to  se l l  you  in su ran ce .  
 
The  Fede ra l  P r i va c y  A c t  p ro te c t s  the  con f iden t ia l i ty  o f  you r  N IH  med i ca l  re co rd s .   Howeve r ,  you  shou ld  know  tha t  the  A c t  
a l low s  re lea se  o f  some  in fo rma t ion  f rom  you r  med i ca l  re co rd  w i thou t  you r  pe rm i s s ion ,  fo r  e xamp le ,  i f  i t  i s  requ i red  b y  the  Food  and  D rug  Admin i s t ra t ion  (FDA ) ,  membe r s  o f  Cong re s s ,  law  en fo r cemen t  o f f i c ia l s ,  o r  au tho r i zed  ho sp i ta l  a c c red i ta t ion  
o rgan i za t ion s .  
 
[ADDRESS_1102009]  an y  p rob lem s  o r  que s t ion s  abou t  th i s  s tud y ,  o r  abou t  you r  r igh t s  a s  a  re s ea r ch  pa r t i c ipan t ,  o r  abou t  an y  re sea r ch- re la ted  in ju r y ,  con ta c t  the  P r in c ipa l  In ve s t iga to r ,  K ie ron  Dun leav y ,  M .D . ;  Bu i ld ing  10 ,  Room  4N115 ,  Te lephone :   301- 435- 1007 .    
 
You  may  a l so  ca l l  the  C l in i ca l  Cen te r  Pa t ien t  Rep re sen ta t i ve  a t  301- 496- 2626 . 
 
5 . Consen t  Documen t .   P lea se  keep  a  cop y  o f  th i s  do cumen t  in  ca se  you  wan t  to  read  i t  aga in . 
COMPLETE  APPROPR IATE  ITEM (S )  BELOW :  
A . Adu l t  Pa t ien t ’s  Consen t B . Pa ren t ’s  Pe rm iss ion  fo r  M ino r  Pa t ien t . 
I   ha ve   read   the   e xp lana t ion   abou t   th i s   s tud y   and   ha ve   been   g i v en   the  
oppo r tun i t y  to  d i s cu s s  i t  and  to  a s k  que s t ion s .   I  he reb y  con sen t  to  ta ke  
pa r t  in  th i s  s tud y . I   ha ve   read   the   e xp lana t ion   abou t   th i s   s tud y   and   ha ve   been   g i ven   the  
oppo r tun i t y  to  d i s cu s s  i t  and  to  a s k  que s t ion s .   I  he reb y  g i ve  pe rm i s s ion  
fo r  m y  ch i ld  to  ta ke  pa r t  in  th i s  s tud y .    
(A t ta ch  N IH  2514 - 2 ,  M ino r ’ s  A s sen t ,  i f  app l i cab le . ) 
        
S igna tu re  o f  Adu l t  Pa t ien t /Lega l  Rep re sen ta t i ve Da te 
 
  
P r in t  Name S igna tu re  o f  Pa ren t ( s ) /Gua rd ian Da te 
 
  
P r in t  Name 
C . Ch i ld ’s  Ve rba l  Assen t  ( I f  App l icab le ) 
The in fo rma t ion  in  the  abo ve  con sen t  wa s  de s c r ibed  to  m y  ch i ld  and  m y  ch i ld  ag ree s  to  pa r t i c ipa te  in  the  s tud y .   
 
       
S igna tu re  o f  Pa ren t ( s ) /Gua rd ian Da te 
 P r in t  Name 
[CONTACT_798947]  13,  20 11  THROUGH  JU NE 12,  2 012 .   
  
        
S igna tu re  o f  In ve s t iga to r Da te 
 
  
P r in t  Name S igna tu re  o f  W i tne s s Da te 
 
  
P r in t  Name 
 
 